LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Trametinib | 3.33 | uM | LJP5 | 1 | P20 | 72 | hr | 658 | 864 | 3908 | 0.2211 | 0.1117 |
Hs 578T | Trametinib | 3.33 | uM | LJP5 | 2 | P20 | 72 | hr | 658 | 928 | 3953 | 0.2347 | 0.1420 |
Hs 578T | Trametinib | 3.33 | uM | LJP5 | 3 | P20 | 72 | hr | 658 | 923 | 3938 | 0.2344 | 0.1400 |
Hs 578T | Trametinib | 10 | uM | LJP5 | 1 | P19 | 72 | hr | 658 | 975 | 3908 | 0.2495 | 0.1652 |
Hs 578T | Trametinib | 10 | uM | LJP5 | 2 | P19 | 72 | hr | 658 | 900 | 3953 | 0.2276 | 0.1286 |
Hs 578T | Trametinib | 10 | uM | LJP5 | 3 | P19 | 72 | hr | 658 | 964 | 3938 | 0.2448 | 0.1593 |
Hs 578T | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 658 | 1196 | 3705 | 0.3227 | 0.2707 |
Hs 578T | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 658 | 1160 | 3807 | 0.3047 | 0.2508 |
Hs 578T | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 658 | 1152 | 3769 | 0.3056 | 0.2490 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 658 | 903 | 3705 | 0.2437 | 0.1352 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 658 | 925 | 3807 | 0.2429 | 0.1438 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 658 | 911 | 3769 | 0.2417 | 0.1378 |
Hs 578T | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 658 | 631 | 3705 | 0.1703 | -0.0168 |
Hs 578T | Omipalisib | 0.37 | uM | LJP6 | 2 | N04 | 72 | hr | 658 | 648 | 3807 | 0.1702 | -0.0061 |
Hs 578T | Omipalisib | 0.37 | uM | LJP6 | 3 | N04 | 72 | hr | 658 | 682 | 3769 | 0.1809 | 0.0142 |
Hs 578T | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 658 | 514 | 3705 | 0.1387 | -0.0944 |
Hs 578T | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 658 | 540 | 3807 | 0.1418 | -0.0752 |
Hs 578T | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 658 | 496 | 3769 | 0.1316 | -0.1063 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 658 | 469 | 3705 | 0.1266 | -0.1271 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 658 | 448 | 3807 | 0.1177 | -0.1409 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 658 | 392 | 3769 | 0.1040 | -0.1860 |
Hs 578T | Omipalisib | 10 | uM | LJP6 | 1 | N01 | 72 | hr | 658 | 340 | 3705 | 0.0917 | -0.2327 |
Hs 578T | Omipalisib | 10 | uM | LJP6 | 2 | N01 | 72 | hr | 658 | 373 | 3807 | 0.0980 | -0.2009 |
Hs 578T | Omipalisib | 10 | uM | LJP6 | 3 | N01 | 72 | hr | 658 | 347 | 3769 | 0.0920 | -0.2245 |
Hs 578T | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 658 | 3704 | 3908 | 0.9477 | 0.9586 |